Mark Bachleda
Chief Commercial Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Galera Therapeutics, Inc. (GRTXD) | Pharm.D., Chief Commercial Officer | $475,000 | $788,626 |
| 2021 | Galera Therapeutics, Inc. (GRTXD) | Pharm.D., Chief Commercial Officer | $109,920 | $1,288,415 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.